VM-PSY-003
A combination therapy in development to support patients seeking treatment for opioid use disorder.
VM-PAIN-001
An oral extended-release formulation being developed for individuals living with severe chronic pain.
VM-RHE-003
A repurposed oral therapy being developed for chronic pain conditions such as fibromyalgia.
VM-PSY-002
A fixed-dose combination being evaluated as a potential treatment option for individuals with cocaine use disorder.
VM-NEU-001
A regenerative therapeutic candidate in development for neurodegenerative diseases, beginning with Parkinson’s disease.
VM-PSY-001
An investigational oral therapy being developed for individuals with alcohol use disorder.
VM-RHE-001
A localized treatment being developed to address unmet needs in patients with gout.